Status:
RECRUITING
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
Lead Sponsor:
Rutgers, The State University of New Jersey
Conditions:
Antibiotic Treatment
Eligibility:
All Genders
1-4 years
Phase:
PHASE1
Brief Summary
Antibiotics are lifesaving therapeutic drugs which have been used by adults, children, and infants alike for decades. There is an increase in global use of antibiotics over the course of lifetime and ...
Detailed Description
Antibiotics are lifesaving therapeutic drugs which have been used by adults, children, and infants alike for decades. There is an increase in global use of antibiotics over the course of lifetime and ...
Eligibility Criteria
Inclusion
- healthy infants and toddlers 1 month to 4 years of age (regardless of birth mode, sex, or diet (breastmilk, formula, solids, etc.)
Exclusion
- Child's antibiotic use within 3 months before inclusion in the study
- Documented immunological condition from the child's pediatrician
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06609980
Start Date
August 1 2024
End Date
September 1 2027
Last Update
September 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Department of Biochemistry & Microbiology
New Brunswick, New Jersey, United States, 08901